secwatch.observer — SEC 8-K summary
======================================

Issuer:     Citius Pharmaceuticals, Inc. (CTXR)
CIK:        0001506251
Form:       8-K
Filed at:   2025-05-30T23:59:59+00:00
Accession:  0001213900-25-049550
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Pharma receives Nasdaq delisting notice for bid price non-compliance
---------------------------------------------------------------------------

- Received Nasdaq letter on May 29, 2025 for failing minimum $1 bid price for 33 consecutive business days.
- Not eligible for compliance period due to reverse stock split within prior year.
- Plans to appeal by June 5, 2025 to stay suspension; delisting would start June 9 without appeal.
- No assurance that Nasdaq will grant relief or that compliance can be regained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506251/000121390025049550/0001213900-25-049550-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506251/000121390025049550/ea0244023-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-049550

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer